Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jan 16, 2013
For more info, visit http://www.bio-rad.com/yt/10/proteonw.... In this webinar, Tsafrir Bravman of Bio-Rad Laboratories continues the SPR Expert series by presenting a case study using the ProteOn XPR36 system to study the interactions of two protein kinases, p38 and ERK2, with a panel of small-molecule inhibitors conducted in collaboration with Chugai Pharmaceuticals, Japan. The results of their screening program are presented and discussed, followed by an overview of best practices for small-molecule assay configuration and particular considerations for this system.
Presenter: Tsafrir Bravman, PhD Manager, SPR Applications Group Bio-Rad Laboratories
Our mission: To provide useful, high-quality products and services that advance scientific discovery and improve healthcare. At Bio-Rad, we are united behind this effort. These two objectives are the driving force behind every decision we make, from developing innovative ideas to building global solutions that help solve our customers' greatest challenges.